Manaya, Romie G.
HRN: 26-70-40 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/21/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
02/21/2025
02/28/2025
IV
1.5g
Q8
Liver Abcess
Waiting Final Action
Indication: Prophylaxis Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes